SynthesisBMC medicine2015

Influence of CYP19A1 polymorphisms on the treatment of breast cancer with aromatase inhibitors: a systematic review and meta-analysis.

Osvaldo Artigalás et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.